GNLX

Genelux Corporation

8.09 USD
+1.42 (+21.29%)
Last updated
This page is just a preview of the data found in TrendSpider’s full version

Genelux Corporation stock is down -21.23% since 30 days ago. The next earnings date is Mar 8, 2024. The company has had above-average volume in the last 30 days. Its seasonality going into this month shows a chance of a green month, as 50% of the previous 1 February’s closed higher than January.

About Genelux Corporation

Genelux is a clinical-stage biopharmaceutical company focused on developing a pipeline of next-generation oncolytic viral immunotherapies for patients suffering from aggressive and/or difficult-to-treat solid tumor types. Our principal executive offices are located at 2625 Townsgate Road, Suite 230, Westlake Village, California.